Swiss Water Announces TSX Approval for Share Buyback under an NCIB
VANCOUVER, British Columbia, Aug. 17, 2026 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (TSX:SWP) (“Swiss Water” or…
CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD)
Susvimo is the first and only continuous delivery treatment that offers an alternative to standard of care eye…
Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN
Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically meaningful improvements of…
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
First gene replacement therapy in the EU for broad population with SMA, including children two years and older,…
Roche Advances in Alzheimer’s Diagnostics with New Blood Test Approval
Roche, Advances
17.03.2026 – 05:26:16 | boerse-global.de
Roche gains CE mark for a blood…